0;in Quarterly Reports on Form 10-Q we have filed or will file hereafter.
We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from those contained in the forward-looking statements.
This cautionary statement is applicable to all forward-looking statements contained in this press release.
Use of Non-GAAP Financial InformationA reconciliation of the Company's non-GAAP financial measures to the corresponding GAAP measures, and an explanation of the Company's use of these non-GAAP financial measures, is included in the exhibits attached to this press release. CONTACT:
Denise Kaigler508-650-8330 (office)Media RelationsBoston Scientific Corporationdenise.firstname.lastname@example.orgErik Kopp508-650-8660 (office)Media RelationsBoston Scientific Corporationerik.email@example.comSean Wirtjes508-652-5305 (office)Investor RelationsBoston Scientific Corporationinvestor_relations@bsci.comBOSTON SCIENTIFIC CORPORATIONCONDENSED CONSOLIDATED GAAP RESULTS OF OPERATIONS
(Unaudited)Three Months EndedNine Months EndedSeptember 30,September 30,in millions, except per share data
5,804Cost of products sold
3,865Operating expenses:Selling, general and administrative expenses
1,897Research and development expenses
381Goodwill impairment net charges
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Related medicine technology :1
|SOURCE Boston Scientific Corporation|
Copyright©2010 PR Newswire.
All rights reserved
. Boston Scientific Completes Enrollment in Benign Stricture Study of WallFlex® Biliary RX Stent2
. Boston Scientific Launches Promus Element™ Stent System In China3
. Boston Scientific Welcomes Introduction of Medical Device Regulatory Improvement Act in U.S. Senate4
. Boston Scientific To Webcast Conference Call Discussing Third Quarter 2011 Financial Results5
. COPAN WASP® Lands at Prestigious Boston Medical Center6
. Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial7
. Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement of Johnson & Johnson Patent8
. Bluestar Silicones to Present Antimicrobial Silicones at Medical Silicones Conference in Boston9
. Clinical Data Demonstrates Long-Term Safety of Boston Scientifics Alair[TM]Bronchial Thermoplasty System10
. Boston Scientific Launches Coyote™ Balloon Catheter11
. Boston Scientific Sponsors New Patient Portal Dedicated to Pelvic Floor Disorders